Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)

被引：0

作者：

R. Andrés

I. Pajares

J. Balmaña

G. Llort

T. Ramón y Cajal

I. Chirivella

E. Aguirre

L. Robles

E. Lastra

P. Pérez-Segura

N. Bosch

C. Yagüe

E. Lerma

J. Godino

M. D. Miramar

M. Moros

P. Astier

B. Saez

M. J. Vidal

A. Arcusa

S. Ramón y Cajal

M. T. Calvo

A. Tres

机构：

[1] Servicio de Oncología Médica,

[2] Hospital Clínico Lozano Blesa,undefined

[3] Hospital Vall d′Hebron de Barcelona,undefined

[4] Instituto Oncológic del Vallés,undefined

[5] Hospital de la Santa Creu y San Pau de Barcelona,undefined

[6] Hospital Clínico de Valencia,undefined

[7] Hospital Arnau de Vilanova de Lérida,undefined

[8] Hospital Universitario 12 de Octubre,undefined

[9] Hospital G. Yagüe de Burgos,undefined

[10] Hospital Clínico San Carlos de Madrid,undefined

[11] Aragon Health Science Institute,undefined

[12] Hospital Universitario Miguel Servet,undefined

[13] Centro de Salud San Pablo,undefined

[14] Hospital Valle Hebron,undefined

来源：

Clinical and Translational Oncology | 2014年 / 16卷

关键词：

Triple negative breast cancer; BRCA1; Hereditary breast cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：280 / 284

页数：4

共 50 条

[21] Frequent BRCA1/2 and BARD1 germline mutations in triple-negative breast cancer patients.
De Greve, Jacques
De Brakeleer, Sylvia
Desmedt, Christine
Joris, Sofie
Sotiriou, Christos
Piccart-Gebhart, Martine J.
Pauwels, Ingrid
Teugels, Erik
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[22] The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer
Villarreal-Garza, C.
Weitzel, J. N.
Llacuachaqui, M.
Sifuentes, E.
Magallanes-Hoyos, M. C.
Gallardo, L.
Alvarez-Gomez, R. M.
Herzog, J.
Castillo, D.
Royer, R.
Akbari, Mohammad
Lara-Medina, F.
Herrera, L. A.
Mohar, A.
Narod, S. A.
BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (02) : 389 - 394
[23] The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer
C. Villarreal-Garza
J. N. Weitzel
M. Llacuachaqui
E. Sifuentes
M. C. Magallanes-Hoyos
L. Gallardo
R. M. Alvarez-Gómez
J. Herzog
D. Castillo
R. Royer
Mohammad Akbari
F. Lara-Medina
L. A. Herrera
A. Mohar
S. A. Narod
Breast Cancer Research and Treatment, 2015, 150 : 389 - 394
[24] BRCA1 and BRCA2 germline mutational spectrum in Algerian triple negative breast cancer (TNBC) patients
Cherbal, Farid
Mehemmai, Chiraz
Gaceb, Hadjer
Mahfouf, Hassen
Boualga, Kada
CANCER RESEARCH, 2022, 82 (12)
[25] Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives
Abdel-Razeq, Hikmat
Tamimi, Faris
Abujamous, Lama
Edaily, Sara
Abunasser, Mahmoud
Bater, Rayan
Salama, Osama
CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4597 - 4604
[26] Germline Mutations in Triple-Negative Breast Cancer
Hahnen, Eric
Hauke, Jan
Engel, Christoph
Neidhardt, Guido
Rhiem, Kerstin
Schmutzler, Rita K.
BREAST CARE, 2017, 12 (01) : 15 - 19
[27] Prevalence of BRCA1 mutations among 284 women with triple-negative breast cancer
Fostira, F.
Tsitlaidou, M.
Gogas, H.
Pertesi, M.
Yannoukakos, D.
Bournakis, E.
Karavassilis, V.
Skarlos, P.
Konstantopoulou, I.
Fountzilas, G.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[28] Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
Rummel, Seth
Varner, Erika
Shriver, Craig D.
Ellsworth, Rachel E.
BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 119 - 125
[29] Prevalence of BRCA1 mutations in women with triple-negative breast cancer: A systematic review
Tun, N. M.
Villani, G. M.
Ong, K.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
[30] Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
Seth Rummel
Erika Varner
Craig D. Shriver
Rachel E. Ellsworth
Breast Cancer Research and Treatment, 2013, 137 : 119 - 125

← 1 2 3 4 5 →